Abiopharma

🔍 Viggiano Aidan (Executive)

Company: TWILIO INC (TWLO)

Report Date: 2026-04-02

Detailed Transactions and Holdings:

• Sold 4,342 shares of Class A Common Stock at $127.0229 per share (Direct)
  Date: 2026-04-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 135,388.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 5,047 shares of Class A Common Stock at $127.9339 per share (Direct)
  Date: 2026-04-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 130,341.00 | transaction_form_type: 4 | Footnotes: F1, F4, F3

Footnotes:

• F1: The sale reported was executed under the Reporting Person's 10b5-1 trading plan, dated as of 6/6/2025.
• F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.50 to $127.44 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F3: A portion of these shares represent RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock.
• F4: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.50 to $128.11 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.